Hint mode is switched on Switch off
For swift navigation between sections

Centogene
LEI 391200UPSSSXC8C1DL91

Organization name
Centogene
Country name
Germany
Country of registration
Germany
Industry
Medical Services
Public debt
-
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Quotes

Request sent
Access denied
Quotes provided by information providers are indicative in nature

Profile

Centogene is a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies. The Company’s goal is to bring rationality to treatment decisions and to accelerate the development of new orphan drugs by using our knowledge of the global rare disease market, including epidemiological and clinical data and innovative biomarkers. Centogene has developed a global proprietary rare disease platform based on our real-world data repository with over 2.0 billion weighted data points from over 450,000 patients representing 115 different countries as of August 31, 2019, or an average of over 500 data points per patient.

Awards

Documentation

IFRS/US GAAP reports

2023
2022
2021
2020
2019
Show all Hide
Authorization required
You need to request access

Stocks

Public debt by currencies

Codes

  • LEI
    391200UPSSSXC8C1DL91
  • SIC
    8071 SERVICES-MEDICAL LABORATORIES
  • NACE
    *** ***
  • NAICS
    *** ***
  • CIK
    0001757097
Registration is required to get access.